Cargando…
SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis
Human hexokinase 2 is an essential regulator of glycolysis that couples metabolic and proliferative activities in cancer cells. The binding of hexokinase 2 to the outer membrane of mitochondria is critical for its oncogenic activity. However, the regulation of hexokinase 2 binding to mitochondria re...
Autores principales: | Shangguan, Xun, He, Jianli, Ma, Zehua, zhang, Weiwei, Ji, Yiyi, Shen, Kai, Yue, Zhiying, Li, Wenyu, Xin, Zhixiang, Zheng, Quan, Cao, Ying, Pan, Jiahua, Dong, Baijun, Cheng, Jinke, Wang, Qi, Xue, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985146/ https://www.ncbi.nlm.nih.gov/pubmed/33753739 http://dx.doi.org/10.1038/s41467-021-22163-7 |
Ejemplares similares
-
Docetaxel remodels prostate cancer immune microenvironment and enhances checkpoint inhibitor-based immunotherapy
por: Ma, Zehua, et al.
Publicado: (2022) -
Immune infiltration phenotypes of prostate adenocarcinoma and their clinical implications
por: Ma, Zehua, et al.
Publicado: (2021) -
SUMOylation-Mediated Response to Mitochondrial Stress
por: He, Jianli, et al.
Publicado: (2020) -
A study on the two binding sites of hexokinase on brain mitochondria
por: Golestani, Abolfazl, et al.
Publicado: (2007) -
Hexokinases inhibit death receptor–dependent apoptosis on the mitochondria
por: Lauterwasser, Joachim, et al.
Publicado: (2021)